Compare VIVO & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VIVO | ABVC |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.5M | 34.6M |
| IPO Year | N/A | 2009 |
| Metric | VIVO | ABVC |
|---|---|---|
| Price | $4.75 | $1.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 120.6K |
| Earning Date | 05-23-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.14 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $509,589.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.97 | $0.88 |
| 52 Week High | $6.86 | $4.02 |
| Indicator | VIVO | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 50.58 | 46.18 |
| Support Level | $4.24 | $1.18 |
| Resistance Level | $5.25 | $1.47 |
| Average True Range (ATR) | 0.80 | 0.13 |
| MACD | -0.18 | -0.01 |
| Stochastic Oscillator | 20.44 | 17.42 |
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.